Dr. Hessel Kooistra Iii, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 10971 Rocky Creek Rd, Fayetteville, AR 72701 Phone: 479-841-2736 |
Johnny P Adkins, MD General Practice Medicare: Medicare Enrolled Practice Location: 3053 N College Avenue, Fayetteville, AR 72703 Phone: 479-463-2000 Fax: 479-442-4518 |
Deborah Brett Bibb, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1188 N Salem Rd, Suite 6, Fayetteville, AR 72704 Phone: 479-442-0006 Fax: 479-442-3038 |
George A Mccrary, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1188 N Salem Rd, Suite 6, Fayetteville, AR 72704 Phone: 479-442-0006 Fax: 479-442-3038 |
Linda M Ekman, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 117 E Sycamore St, Fayetteville, AR 72703 Phone: 479-521-0200 Fax: 479-521-4942 |
Dr. Regina R Hudec, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 3017 N Bob Younkin Dr, Suite 101, Fayetteville, AR 72703 Phone: 479-521-1484 Fax: 479-521-1550 |
Janet Lynn Titus, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 63 W Sunbridge Dr, Fayetteville, AR 72703 Phone: 479-582-3366 Fax: 479-582-5843 |
Dr. Lynn Covey Morrison, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 2031 S Cherry Hills Dr, Fayetteville, AR 72701 Phone: 479-530-6295 |
News Archive
The American Association of Critical-Care Nurses (AACN) recently awarded a $50,000 AACN Impact Research Grant to Brigit Carter, RN, PhD, MSN, CCRN, assistant clinical professor at Duke University School of Nursing, Durham, N.C., to study feeding intolerance in preterm infants.
Helicobacter pylori (H. pylori) are considered to be the most important etiological agents of chronic gastritis. The eradication of H. pyloridepends on the combination of antibiotics and acid suppression drugs.
"Private philanthropists in the European Union and the U.S. spent some $644 million on global HIV/AIDS programs in 2011, a five percent increase from 2010, largely driven by funding from a small number of large donors, a new report has revealed," IRIN reports.
According to new results from the WELCOME trial, exploratory data analyzing the impact of treatment with CIMZIA(®) (certolizumab pegol) - the only PEGylated anti-TNF (alpha) (Tumor Necrosis Factor alpha) - administered either every two weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the 26-week study.
Most people who smoke e-cigarettes want to quit and many have tried to reduce their use, according to Rutgers researchers.
› Verified 8 days ago